Agilent AdvanceBio Peptide Plus Columns

Brochures and specifications | 2025 | Agilent TechnologiesInstrumentation
Consumables, LC columns
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Significance of the Topic


Characterization of therapeutic peptides and proteins requires high resolution and reproducibility to monitor critical quality attributes such as post-translational modifications, impurities, and degradation products. Robust LC/MS methods simplify transfer between research, QA/QC, and release testing, accelerating biologics development.

Objectives and Study Overview


The study evaluates Agilent AdvanceBio Peptide Plus columns under formic acid mobile phase conditions. Goals include comparing performance with traditional C18, assessing resolution of modified and unmodified peptides, testing impurity separations, and examining column loadability and lot-to-lot consistency.

Methodology


AdvanceBio Peptide Plus columns utilize superficially porous Poroshell technology with a hybrid endcapped C18 phase modified to carry a charged surface. Key parameters:
  • Particle size: 2.7 μm, pore size: 100 Å
  • Mobile phase: 0.1% formic acid in water and acetonitrile
  • Typical gradient elution and flow rates of 0.4 mL/min
  • Column temperatures around 55–60 °C

Used Instrumentation


  • Agilent AdvanceBio Peptide Plus LC columns (various dimensions)
  • Agilent 6545XT AdvanceBio LC/Q-TOF system
  • Agilent AssayMAP Bravo sample preparation platform
  • Agilent MassHunter and OpenLab chromatography software

Main Results and Discussion


  • Improved resolution of deamidated peptides compared to standard C18, enabling clear separation of modified forms.
  • Efficient separation of synthetic peptide impurities (e.g., bivalirudin and its variants) under a single FA method, supporting both UV and MS detection.
  • Stable peak shapes and retention times even at high sample loads up to 30 μg, facilitating detection of low-abundance components.
  • Distinct alternate selectivity for critical peptide pairs that are unresolved on conventional C18 columns.
  • Consistent batch-to-batch performance validated with peptide mapping standards under FA LC/MS conditions.

Benefits and Practical Applications


  • Streamlines method development by using a single FA-friendly mobile phase across platforms.
  • Supports both discovery and QA/QC workflows without method redevelopment.
  • High loadability enhances sensitivity for trace impurities and host cell protein peptides.
  • Alternate selectivity improves separation of post-translational modifications and peptide variants.

Future Trends and Applications


Integration of charged surface stationary phases with multi-dimensional separations and higher throughput LC/MS platforms will further accelerate biologics characterization. Emerging AI-driven data analysis and automated workflows will enhance reproducibility and speed. Adaptation to novel peptide chemistries and coupling with advanced detectors promise broader applications in proteomics and quality control.

Conclusion


Agilent AdvanceBio Peptide Plus columns deliver superior peak shape, resolution, and reproducibility under MS-compatible formic acid conditions. Their charged surface technology and robust manufacturing ensure reliable performance from early development through QA/QC, making them an essential tool for peptide and protein analysis.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

AdvanceBio Peptide Plus - Peptide Characterization
AdvanceBio Peptide Plus - Peptide Characterization
2020|Agilent Technologies|Presentations
Enhancing The Quality Of Peptide Mapping Separation For The Analysis Of PTM
Separation of Deamidated Peptides with an Agilent AdvanceBio Peptide Plus Column
PEEK-lined columns and bio-inert supplies to complement the Agilent 1290 Infinity II bio LC system